May, 2024

article thumbnail

Slideshow: The 5 Types of Asthma and Their Common Triggers

Drug Topics

While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.

618
618
article thumbnail

Why AlphaFold 3 is stirring up so much buzz in pharma

PharmaVoice

The “Nobel Prize-worthy invention” could be worth hundreds of billions commercially — and have a deep impact on drug R&D.

305
305
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacy Influencers Share How to Balance Passions and Career

Pharmacy Times

Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.

180
180
article thumbnail

NIH documents show how $1.6 billion long Covid initiative has failed so far to meet its goals

STAT

More than three years ago, the National Institutes of Health launched a $1 billion-plus initiative to find the root causes and potential treatments for long Covid , the chronic disease that has quickly changed the lives of millions of Americans. But a lack of visible progress from the initiative, called RECOVER, has drawn months of criticism from patient advocates, researchers, and lawmakers, including at a Senate hearing last week on the NIH’s budget.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Revealed: key files shredded as UK government panic grew over infected blood deaths lawsuit

The Guardian - Pharmaceutical Industry

Lost documents prevented victims from finding out the truth, official inquiry told Disastrous failures that caused the contaminated blood scandal were denied by ministers for decades after officials destroyed, lost and blocked access to key documents, memos submitted to the official inquiry reveal. Several batches of files involving the work of a blood safety advisory committee were shredded as the government faced the threat of legal action, documents show.

article thumbnail

Justice Department 'upping its game' on healthcare antitrust enforcement with new task force

Fierce Healthcare

The U.S. Department of Justice announced Thursday it has established a new task force to take on healthcare monopolies and collusion. | The U.S. Department of Justice announced Thursday it has established a new task force to take on healthcare monopolies and collusion.

145
145

More Trending

article thumbnail

As drug shortages reach record highs, regulators float next steps

PharmaVoice

With many chemo and ADHD drugs stuck in stubborn shortages, several agencies are looking for new solutions to boost supplies.

298
298
article thumbnail

Counsel Patients on Nutrition and Following a Balanced Diet Complementary to GLP-1s

Pharmacy Times

The GLP-1 market is expected to exceed $100 billion by 2023, according to J.P. Morgan Research, with total users in the United States projected to reach 30 million.

158
158
article thumbnail

A third U.S. farm worker infected with bird flu is the first to experience respiratory symptoms

STAT

A third human case of H5 bird flu tied to the ongoing U.S. outbreak in cattle has been detected in a farm worker in Michigan, state health authorities confirmed on Thursday. The unnamed individual worked on a dairy farm and was in close contact with infected cows, the state health department said in a statement. The farm involved is different from the one where an earlier human case was detected last week.

145
145
article thumbnail

Obesity is Common in Individuals with Celiac Disease

Drug Topics

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

580
580
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Fentanyl Education, Prevention Key to Ending Crisis in US

Drug Topics

For National Fentanyl Awareness Day, Drug Topics talked with Scott H. Silverman about how public health leaders can address the fentanyl crisis and the best ways to educate the public on the dangers of fentanyl use.

564
564
article thumbnail

COVID-19 Vaccine Booster Dose Beneficial to Immunocompromised Patients

Drug Topics

A recent study found that, of 423 participants who were initially low responders, 90% increased their antibody concentrations to more than 400 AU/mL.

Vaccines 551
article thumbnail

CGM Use Linked to Improved Diabetic Retinopathy Outcomes in T1D

Drug Topics

The current study highlights the potential benefit of incorporating continuous glucose monitor (CGM) data into eye care assessments for patients with type 1 diabetes (T1D).

550
550
article thumbnail

Ascension Hospitals Face Disruptions from Suspected Cyberattack

Drug Topics

The company, which operates 140 care sites across the country, was forced to shut down health systems earlier this week because of the disruption.

Hospitals 546
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Q&A: CVS Pharmacy Technician on Rhode Island Unionization Efforts

Drug Topics

Chris DesRochers, a pharmacy technician who works at a CVS in Wakefield, Rhode Island and is active in the recent organizing, discusses what motivated him and his coworkers to unionize.

530
530
article thumbnail

Pharmacist-Provided Care for Common Conditions Could Increase Access, Save Money

Drug Topics

A recent study found that if community pharmacists were utilized to treat common conditions, it could result in significant cost-savings for the health care system.

528
528
article thumbnail

Study Reveals Robust Benefits of Semaglutide in Protecting Against Kidney, CV Events in Patients With T2D

Drug Topics

Semaglutide reduced the risk of major kidney disease and cardiovascular (CV) events, and death from any cause, while simultaneously decelerating the loss of kidney function, among patients with type 2 diabetes (T2D) and CKD compared to placebo.

528
528
article thumbnail

Mental Health Awareness Month: Resources Roundup

Drug Topics

Check out this list of resources to share with patients who are experiencing mental health conditions.

530
530
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Sunscreen Safety: What Every Pharmacist Needs to Know

Drug Topics

Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?

529
529
article thumbnail

Pharmacogenetic Testing Recommendations Needed in Clinical Guidelines to Increase Consistency

Drug Topics

A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.

527
527
article thumbnail

Walgreens to Start Selling its Own OTC Naloxone Nasal Spray

Drug Topics

The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.

525
525
article thumbnail

Reviewing Efficacy, Safety of Weight Loss Therapies in T1D

Drug Topics

Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.

516
516
article thumbnail

Q&A: Clinical Pearls in Skin Cancer Awareness for the Community Pharmacist

Drug Topics

For Melanoma and Skin Cancer Awareness Month, Drug Topics sat down with Colleen McCabe, PharmD, BCOP, to glean clinical insights into promoting skin cancer awareness in the community pharmacy.

article thumbnail

FDA Approves Onyda XR, First and Only Liquid Nonstimulant for ADHD

Drug Topics

The drug will be available in pharmacies during the second half of 2024.

FDA 503
article thumbnail

FDA Approves Breyanzi to Treat Relapsed or Refractory Mantle Cell Lymphoma

Drug Topics

The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.

FDA 503
article thumbnail

Omega-3 Fatty Acids May Lower Colorectal Cancer Risk

Drug Topics

Research presented at Digestive Disease Week suggests that including omega-3 rich foods, or omega-3 supplements, into a healthy diet could offer additional protection against colorectal cancer alongside regular screening.

100
100
article thumbnail

Q&A: How Coffee Helped This Pharmacy Improve Front-End Sales

Drug Topics

Chris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, sat down with Drug Topics to discuss his joint business venture.

503
503
article thumbnail

Slideshow: AI in Skin Cancer Awareness Creates New Opportunities for Care

Drug Topics

Research exploring the growing role of artificial intelligence (AI) in health care sheds a light on the potential of the technology to improve skin cancer detection and awareness among patients and health care professionals.

501
501
article thumbnail

FDA Approves Updated Label for Altuviiio for Effective Bleed Protection in Children Younger than 12 Years

Drug Topics

Altuviiio was first granted approval by the FDA in February 2023.

Labelling 503
article thumbnail

Insulin App Recall Prompts FDA Warning After More Than 200 Reported Injuries

Drug Topics

Tandem Diabetes Care, Inc has reported 224 injuries associated with a software malfunction in a companion insulin app, leading the company to issue a recall of the technology.

FDA 503
article thumbnail

FDA Approves Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer

Drug Topics

Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.

FDA 501
article thumbnail

Type 2 Diabetes Impacts Mental Health, but Continuous Glucose Monitors Can Help

Drug Topics

A report from Dexcom found that depression and anxiety are commonly reported in patients living with type 2 diabetes, but continuous glucose monitors can make disease management easier.

500
500
article thumbnail

FDA Approves Second Formulation of Humira Biosimilar Cyltezo

Drug Topics

According to Michael Osso, president and chief executive officer of the Crohn’s & Colitis Foundation, “the flexibility of having multiple biosimilar formulations to choose from is important to support broader patient access to biologic medicine.

FDA 503